Signal Generation in the New Zealand Intensive Medicines Monitoring Programme
- 1 January 2002
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 25 (6) , 433-439
- https://doi.org/10.2165/00002018-200225060-00007
Abstract
The New Zealand Intensive Medicines Monitoring Programme (IMMP) undertakes prospective observational cohort studies on selected new drugs in the early postmarketing period using prescription-event...Keywords
This publication has 4 references indexed in Scilit:
- The New Zealand intensive medicines monitoring programme in pro-active safety surveillancePharmacoepidemiology and Drug Safety, 2000
- A comparison of the use, effectiveness and safety of bezafibrate, gemfibrozil and simvastatin in normal clinical practice using the New Zealand Intensive Medicines Monitoring Programme (IMMP)British Journal of Clinical Pharmacology, 1999
- The New Zealand intensive medicines monitoring programmePharmacoepidemiology and Drug Safety, 1998
- Causality classification at pharmacovigilance centres in the european communityPharmacoepidemiology and Drug Safety, 1992